Management & Regulatory

The COVID-19 pandemic brought unprecedented challenges to educational systems worldwide, and Maine was no exception. When schools closed in March 2020, the Maine Department of Education (DOE) quickly recognized the need to address the mental health of both students and educators. This article

Freya Biosciences, a transatlantic biotech company specializing in women's health, has successfully secured a substantial $10.4 million investment from the Bill & Melinda Gates Foundation, along with an additional $1.4 million in financing from the Export and Investment Fund of Denmark.

The Mesenchymal Stem Cells (MSC) market is experiencing rapid growth, driven by an aging global population, advancements in regenerative medicine, and technological innovations in biotechnology. Valued at USD 3.2 billion in 2023, the market is anticipated to reach USD 9.72 billion by 2032, with a

The Rocky Mountain Lions Eye Bank (RMLEB) is a nonprofit organization responsible for procuring corneas in Wyoming and Colorado. Despite its noble mission, the organization faces significant operational challenges, regulatory issues, and a high-pressure work environment. These problems have led to

The Immunomodulators Market is on the cusp of exponential growth, with forecasts predicting an increase from roughly USD 217.7 billion in 2023 to an estimated USD 388.7 billion by 2032. This significant rise, characterized by an impressive compound annual growth rate (CAGR) of 6.7%, is largely

With President-elect Donald J. Trump officially moving into the White House, manufacturing business leaders have quickly laid out their top priorities for his administration, eager to see substantial changes that will benefit their industry. Among the most prominent of these priorities is the